Skip to main content
Professionals
Capabilities
Insights
Locations
Our Firm
News
Events
Careers
search menu
Search
English
Deutsch
English (United Kingdom)
español
עברית
italiano
日本語
한국어
Nederlands
polski
português
中文
Search
submit search
{{typeahead}}
2006
Published Article
Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and In Vivo Antiinflammatory Activity
Capabilities
Life Sciences & Medical Technology
Offices
Boston
Share
John Buchanan co-authored an article titled "Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and In Vivo Antiinflammatory Activity" in the
Journal of Medicinal Chemistry
.
You May Also Be Interested In:
June 06, 2022 - June 07, 2022
Event
DeviceTalks Minnesota
May 19, 2022
Press Release
Greenberg Traurig Recognized as ‘Patent Strategy Firm of the Year’ by LMG Life Sciences EMEA
2 min read
May 17, 2022 - May 18, 2022
Event
Yale Innovation Summit 2022